about
Intraarterial platelet infusion for patients with intractable gastrointestinal hemorrhage and severe refractory thrombocytopenia.Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.Detection of gliotoxin in experimental and human aspergillosisTransplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trialThymic function and allogeneic T-cell responses in stem-cell transplantation.Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.Vaccines in leukemia.Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.Lymphoid reconstruction and vaccines.Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.2E8 binds to the high affinity I-domain in a metal ion-dependent manner: a second generation monoclonal antibody selectively targeting activated LFA-1.Co-engagement of alpha(4)beta(1) integrin (VLA-4) and CD4 or CD8 is necessary to induce maximal Erk1/2 phosphorylation and cytokine production in human T cells.Human late memory CD8+ T cells have a distinct cytokine signature characterized by CC chemokine production without IL-2 production.Vitamin D receptor upregulation in alloreactive human T cells.High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation.Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes.Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.Deficient T(H)-1 responses from TNF-alpha-matured and alpha-CD40-matured dendritic cells.Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help.Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation.Innately interesting interactions.American Society of Blood and Marrow Transplantation Guidelines for Training in Hematopoietic Progenitor Cell Transplantation.Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis.Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity.Divining T-cell targets for cancer immunotherapyRestoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cellsDouble-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood unitsRisk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignanciesFunctional assessment and specific depletion of alloreactive human T cells using flow cytometryGVHD therapy: let there be light!Can Treg therapy prevent GVHD?AML-loaded DC generate Th1-type cellular immune responses in vitroGVHD protection? ThiNK iNKT cellsDeep functional immunophenotyping predicts risk of cytomegalovirus reactivation after hematopoietic cell transplantationNext-generation sequencing of microbial cell-free DNA for rapid noninvasive diagnosis of infectious diseases in immunocompromised hostsIncreased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1
P50
Q33360286-E458BD12-FBBD-4E66-81FB-EB7FF57166E8Q33391089-6E75C817-3BA6-4A59-8EA6-655355000EE1Q33557456-BBA4E703-AF2E-432C-9008-9535D71E61EBQ33861192-AABB3C70-E5B5-44FC-A640-28E64FCC1E70Q34979042-41C671AE-1954-4C5C-B069-D97219FB171CQ35889876-192A2A00-7198-4344-A951-8115215F46D0Q35909318-17A33D9C-E2E7-4EA8-AF02-5540CE52A480Q36363451-7360045E-DB06-458F-8017-B49AFE127BF5Q36707846-96412B40-F28B-46B4-BDF9-B89BF6677067Q39559416-81BF7A11-F09D-4786-8239-EAE03A9574F2Q41892335-AA39AAD4-7EDD-4DB1-B30D-B36E46C7A300Q42951539-94302935-E477-492D-91B6-3FCE91EC97AAQ44402704-9D30CAB3-EFC6-4511-90CE-84D0E08EE4A6Q44770694-40024FF4-55EF-42C8-B270-3AA25DA840E1Q44976339-94211B35-5BD5-4CAD-9E55-7230C2A91EC1Q45152662-D75F760D-720E-429F-8756-BBE3D2ADADDCQ45245159-6D13C245-900F-43B7-A77C-A57DC64893F3Q46594783-025CEB1B-0EB9-4D73-AB0D-DF2E74C82843Q46946456-11719FBE-5D80-4C39-8D49-C5F299528D1CQ46952765-B625C800-4DB4-4530-9DF0-A488AD78114BQ48220213-40267F8D-6B80-428B-8AAF-19AF0FECC4F9Q48573876-A7C1C585-A1EA-4258-9019-3C909BDFCE9CQ51185415-3E8EEA4B-C42C-4EB4-B600-7E27254E1714Q51982574-27A04167-74A1-4F61-91E9-ADCA8A75E021Q58544473-E37675C8-0596-4E42-9501-A1BB32DA4030Q77078276-0BE74D4A-3159-4E79-81C9-28E9880BA81DQ78409838-49DC98B9-7C73-4426-9B7B-BD7E38343673Q78531436-AFF38B27-C1C0-47A4-A707-ABBDA6F9DC67Q80387253-49A28348-5AE3-4DB0-8BD8-B0F6B013DA14Q80396419-8364CAAD-9E18-4433-9C03-7FABAB88CE54Q81751671-16D107E0-F67A-4C26-B449-7D8DECDF4F13Q83253234-B85F85C5-AE45-48A2-8D4A-1F2DFCAD3FEFQ83336977-C044A21E-0274-46C8-A1AF-3B3C18E79A2DQ84944217-ADC6EFAA-4267-415F-87D4-E9001F80EDC9Q90680942-53D18093-243F-4D7F-B683-5793485832C1Q91791862-7B76247A-047B-4495-9360-DDAE979CF2DFQ93021274-74EBC527-1B3C-4CEC-B468-7B20CC380E42
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Krishna V Komanduri
@ast
Krishna V Komanduri
@en
Krishna V Komanduri
@es
Krishna V Komanduri
@nl
Krishna V Komanduri
@sl
type
label
Krishna V Komanduri
@ast
Krishna V Komanduri
@en
Krishna V Komanduri
@es
Krishna V Komanduri
@nl
Krishna V Komanduri
@sl
prefLabel
Krishna V Komanduri
@ast
Krishna V Komanduri
@en
Krishna V Komanduri
@es
Krishna V Komanduri
@nl
Krishna V Komanduri
@sl
P106
P31
P496
0000-0003-3715-5236
P569
2000-01-01T00:00:00Z